nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—SHBG—hindlimb—sarcoma	0.0303	0.134	CbGeAlD
Mitotane—FDX1—seminal vesicle—sarcoma	0.0223	0.0986	CbGeAlD
Mitotane—CYP11B1—hematopoietic system—sarcoma	0.0169	0.0749	CbGeAlD
Mitotane—FDX1—cardiac atrium—sarcoma	0.0161	0.0711	CbGeAlD
Mitotane—FDX1—tendon—sarcoma	0.014	0.062	CbGeAlD
Mitotane—FDX1—bone marrow—sarcoma	0.0136	0.0601	CbGeAlD
Mitotane—FDX1—testis—sarcoma	0.0116	0.0513	CbGeAlD
Mitotane—FDX1—liver—sarcoma	0.011	0.0485	CbGeAlD
Mitotane—CYP11A1—hematopoietic system—sarcoma	0.00962	0.0426	CbGeAlD
Mitotane—CYP11A1—connective tissue—sarcoma	0.00927	0.041	CbGeAlD
Mitotane—SERPINA6—hematopoietic system—sarcoma	0.00915	0.0405	CbGeAlD
Mitotane—FDX1—lymph node—sarcoma	0.00842	0.0372	CbGeAlD
Mitotane—SHBG—hematopoietic system—sarcoma	0.00771	0.0341	CbGeAlD
Mitotane—SHBG—connective tissue—sarcoma	0.00743	0.0328	CbGeAlD
Mitotane—SERPINA6—bone marrow—sarcoma	0.00587	0.026	CbGeAlD
Mitotane—SHBG—uterus—sarcoma	0.00583	0.0258	CbGeAlD
Mitotane—CYP11A1—testis—sarcoma	0.00527	0.0233	CbGeAlD
Mitotane—SHBG—bone marrow—sarcoma	0.00495	0.0219	CbGeAlD
Mitotane—SERPINA6—liver—sarcoma	0.00474	0.021	CbGeAlD
Mitotane—SHBG—testis—sarcoma	0.00423	0.0187	CbGeAlD
Mitotane—SHBG—liver—sarcoma	0.004	0.0177	CbGeAlD
Mitotane—CYP11A1—lymph node—sarcoma	0.00382	0.0169	CbGeAlD
Mitotane—Malnutrition—Thiotepa—sarcoma	0.00281	0.00363	CcSEcCtD
Mitotane—Urethral disorder—Vincristine—sarcoma	0.00281	0.00363	CcSEcCtD
Mitotane—Hepatitis—Mitoxantrone—sarcoma	0.00279	0.00361	CcSEcCtD
Mitotane—Dyskinesia—Epirubicin—sarcoma	0.00276	0.00356	CcSEcCtD
Mitotane—Dysarthria—Epirubicin—sarcoma	0.00274	0.00354	CcSEcCtD
Mitotane—Neutropenia—Etoposide—sarcoma	0.00271	0.0035	CcSEcCtD
Mitotane—Vision blurred—Thiotepa—sarcoma	0.00265	0.00342	CcSEcCtD
Mitotane—Anaemia—Thiotepa—sarcoma	0.0026	0.00336	CcSEcCtD
Mitotane—Angiopathy—Vincristine—sarcoma	0.0026	0.00336	CcSEcCtD
Mitotane—Hepatocellular injury—Epirubicin—sarcoma	0.00259	0.00335	CcSEcCtD
Mitotane—Infestation—Etoposide—sarcoma	0.00259	0.00334	CcSEcCtD
Mitotane—Infestation NOS—Etoposide—sarcoma	0.00259	0.00334	CcSEcCtD
Mitotane—Anaemia—Dactinomycin—sarcoma	0.00258	0.00333	CcSEcCtD
Mitotane—Dyskinesia—Doxorubicin—sarcoma	0.00255	0.0033	CcSEcCtD
Mitotane—Dysarthria—Doxorubicin—sarcoma	0.00253	0.00327	CcSEcCtD
Mitotane—Salivary hypersecretion—Epirubicin—sarcoma	0.00252	0.00325	CcSEcCtD
Mitotane—Mental disorder—Vincristine—sarcoma	0.00251	0.00324	CcSEcCtD
Mitotane—Hepatobiliary disease—Etoposide—sarcoma	0.00244	0.00316	CcSEcCtD
Mitotane—Hypertension—Thiotepa—sarcoma	0.00243	0.00314	CcSEcCtD
Mitotane—Hepatocellular injury—Doxorubicin—sarcoma	0.0024	0.0031	CcSEcCtD
Mitotane—Dysgeusia—Mitoxantrone—sarcoma	0.00238	0.00307	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00238	0.00307	CcSEcCtD
Mitotane—Neoplasm—Epirubicin—sarcoma	0.00234	0.00303	CcSEcCtD
Mitotane—Salivary hypersecretion—Doxorubicin—sarcoma	0.00233	0.00301	CcSEcCtD
Mitotane—Confusional state—Thiotepa—sarcoma	0.00231	0.00299	CcSEcCtD
Mitotane—Anaemia—Vincristine—sarcoma	0.00231	0.00298	CcSEcCtD
Mitotane—Urinary tract disorder—Etoposide—sarcoma	0.00229	0.00296	CcSEcCtD
Mitotane—Vision blurred—Mitoxantrone—sarcoma	0.00229	0.00296	CcSEcCtD
Mitotane—Infection—Thiotepa—sarcoma	0.00228	0.00295	CcSEcCtD
Mitotane—Urethral disorder—Etoposide—sarcoma	0.00227	0.00294	CcSEcCtD
Mitotane—Infection—Dactinomycin—sarcoma	0.00226	0.00292	CcSEcCtD
Mitotane—Nervous system disorder—Thiotepa—sarcoma	0.00225	0.00291	CcSEcCtD
Mitotane—Mental disability—Epirubicin—sarcoma	0.00225	0.0029	CcSEcCtD
Mitotane—Thrombocytopenia—Thiotepa—sarcoma	0.00225	0.0029	CcSEcCtD
Mitotane—Anaemia—Mitoxantrone—sarcoma	0.00224	0.0029	CcSEcCtD
Mitotane—Vertigo—Vincristine—sarcoma	0.00224	0.0029	CcSEcCtD
Mitotane—Thrombocytopenia—Dactinomycin—sarcoma	0.00223	0.00288	CcSEcCtD
Mitotane—Skin disorder—Thiotepa—sarcoma	0.00223	0.00288	CcSEcCtD
Mitotane—Anorexia—Thiotepa—sarcoma	0.00219	0.00283	CcSEcCtD
Mitotane—Anorexia—Dactinomycin—sarcoma	0.00217	0.00281	CcSEcCtD
Mitotane—Eye disorder—Etoposide—sarcoma	0.00217	0.0028	CcSEcCtD
Mitotane—Neoplasm—Doxorubicin—sarcoma	0.00217	0.0028	CcSEcCtD
Mitotane—Flushing—Etoposide—sarcoma	0.00215	0.00278	CcSEcCtD
Mitotane—Hypertension—Vincristine—sarcoma	0.00215	0.00278	CcSEcCtD
Mitotane—Angiopathy—Etoposide—sarcoma	0.00211	0.00272	CcSEcCtD
Mitotane—Hypertension—Mitoxantrone—sarcoma	0.0021	0.00271	CcSEcCtD
Mitotane—Mental disability—Doxorubicin—sarcoma	0.00208	0.00269	CcSEcCtD
Mitotane—Paraesthesia—Thiotepa—sarcoma	0.00206	0.00266	CcSEcCtD
Mitotane—Somnolence—Thiotepa—sarcoma	0.00204	0.00264	CcSEcCtD
Mitotane—Infection—Vincristine—sarcoma	0.00202	0.00261	CcSEcCtD
Mitotane—Dyspepsia—Thiotepa—sarcoma	0.00202	0.00261	CcSEcCtD
Mitotane—Confusional state—Mitoxantrone—sarcoma	0.002	0.00258	CcSEcCtD
Mitotane—Nervous system disorder—Vincristine—sarcoma	0.002	0.00258	CcSEcCtD
Mitotane—Decreased appetite—Thiotepa—sarcoma	0.002	0.00258	CcSEcCtD
Mitotane—Thrombocytopenia—Vincristine—sarcoma	0.00199	0.00258	CcSEcCtD
Mitotane—Gastrointestinal disorder—Thiotepa—sarcoma	0.00198	0.00256	CcSEcCtD
Mitotane—Decreased appetite—Dactinomycin—sarcoma	0.00198	0.00256	CcSEcCtD
Mitotane—Dysgeusia—Etoposide—sarcoma	0.00198	0.00256	CcSEcCtD
Mitotane—Infection—Mitoxantrone—sarcoma	0.00197	0.00254	CcSEcCtD
Mitotane—Pain—Thiotepa—sarcoma	0.00196	0.00254	CcSEcCtD
Mitotane—Shock—Mitoxantrone—sarcoma	0.00195	0.00252	CcSEcCtD
Mitotane—Pain—Dactinomycin—sarcoma	0.00195	0.00252	CcSEcCtD
Mitotane—Thrombocytopenia—Mitoxantrone—sarcoma	0.00194	0.00251	CcSEcCtD
Mitotane—Anorexia—Vincristine—sarcoma	0.00194	0.00251	CcSEcCtD
Mitotane—Skin disorder—Mitoxantrone—sarcoma	0.00193	0.00249	CcSEcCtD
Mitotane—Lethargy—Epirubicin—sarcoma	0.00192	0.00248	CcSEcCtD
Mitotane—Hypotension—Vincristine—sarcoma	0.0019	0.00246	CcSEcCtD
Mitotane—Feeling abnormal—Thiotepa—sarcoma	0.00189	0.00244	CcSEcCtD
Mitotane—Anorexia—Mitoxantrone—sarcoma	0.00189	0.00244	CcSEcCtD
Mitotane—Osteoarthritis—Epirubicin—sarcoma	0.00188	0.00243	CcSEcCtD
Mitotane—Diplopia—Epirubicin—sarcoma	0.00188	0.00243	CcSEcCtD
Mitotane—Feeling abnormal—Dactinomycin—sarcoma	0.00188	0.00243	CcSEcCtD
Mitotane—Anaemia—Etoposide—sarcoma	0.00187	0.00241	CcSEcCtD
Mitotane—Hypotension—Mitoxantrone—sarcoma	0.00185	0.00239	CcSEcCtD
Mitotane—Paraesthesia—Vincristine—sarcoma	0.00183	0.00236	CcSEcCtD
Mitotane—Vertigo—Etoposide—sarcoma	0.00182	0.00235	CcSEcCtD
Mitotane—Body temperature increased—Thiotepa—sarcoma	0.00181	0.00234	CcSEcCtD
Mitotane—Body temperature increased—Dactinomycin—sarcoma	0.0018	0.00233	CcSEcCtD
Mitotane—Paraesthesia—Mitoxantrone—sarcoma	0.00178	0.0023	CcSEcCtD
Mitotane—Lethargy—Doxorubicin—sarcoma	0.00178	0.00229	CcSEcCtD
Mitotane—Decreased appetite—Vincristine—sarcoma	0.00177	0.00229	CcSEcCtD
Mitotane—Ataxia—Epirubicin—sarcoma	0.00177	0.00228	CcSEcCtD
Mitotane—Somnolence—Mitoxantrone—sarcoma	0.00176	0.00228	CcSEcCtD
Mitotane—Gastrointestinal disorder—Vincristine—sarcoma	0.00176	0.00227	CcSEcCtD
Mitotane—Dyspepsia—Mitoxantrone—sarcoma	0.00174	0.00225	CcSEcCtD
Mitotane—Hypertension—Etoposide—sarcoma	0.00174	0.00225	CcSEcCtD
Mitotane—Pain—Vincristine—sarcoma	0.00174	0.00225	CcSEcCtD
Mitotane—Osteoarthritis—Doxorubicin—sarcoma	0.00174	0.00225	CcSEcCtD
Mitotane—Diplopia—Doxorubicin—sarcoma	0.00174	0.00225	CcSEcCtD
Mitotane—Decreased appetite—Mitoxantrone—sarcoma	0.00172	0.00223	CcSEcCtD
Mitotane—Orthostatic hypotension—Epirubicin—sarcoma	0.00172	0.00222	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00171	0.00221	CcSEcCtD
Mitotane—Breast disorder—Epirubicin—sarcoma	0.0017	0.0022	CcSEcCtD
Mitotane—Pain—Mitoxantrone—sarcoma	0.0017	0.00219	CcSEcCtD
Mitotane—Hypersensitivity—Thiotepa—sarcoma	0.00169	0.00219	CcSEcCtD
Mitotane—Hypersensitivity—Dactinomycin—sarcoma	0.00168	0.00217	CcSEcCtD
Mitotane—Confusional state—Etoposide—sarcoma	0.00166	0.00215	CcSEcCtD
Mitotane—Muscular weakness—Epirubicin—sarcoma	0.00166	0.00214	CcSEcCtD
Mitotane—Asthenia—Thiotepa—sarcoma	0.00165	0.00213	CcSEcCtD
Mitotane—Infection—Etoposide—sarcoma	0.00164	0.00212	CcSEcCtD
Mitotane—Ataxia—Doxorubicin—sarcoma	0.00164	0.00211	CcSEcCtD
Mitotane—Asthenia—Dactinomycin—sarcoma	0.00163	0.00211	CcSEcCtD
Mitotane—Feeling abnormal—Mitoxantrone—sarcoma	0.00163	0.00211	CcSEcCtD
Mitotane—Thrombocytopenia—Etoposide—sarcoma	0.00161	0.00209	CcSEcCtD
Mitotane—Body temperature increased—Vincristine—sarcoma	0.00161	0.00208	CcSEcCtD
Mitotane—Skin disorder—Etoposide—sarcoma	0.0016	0.00207	CcSEcCtD
Mitotane—Orthostatic hypotension—Doxorubicin—sarcoma	0.00159	0.00205	CcSEcCtD
Mitotane—Breast disorder—Doxorubicin—sarcoma	0.00157	0.00203	CcSEcCtD
Mitotane—Anorexia—Etoposide—sarcoma	0.00157	0.00203	CcSEcCtD
Mitotane—Diarrhoea—Thiotepa—sarcoma	0.00157	0.00203	CcSEcCtD
Mitotane—Body temperature increased—Mitoxantrone—sarcoma	0.00157	0.00202	CcSEcCtD
Mitotane—Diarrhoea—Dactinomycin—sarcoma	0.00156	0.00201	CcSEcCtD
Mitotane—Hypotension—Etoposide—sarcoma	0.00154	0.00199	CcSEcCtD
Mitotane—Muscular weakness—Doxorubicin—sarcoma	0.00153	0.00198	CcSEcCtD
Mitotane—Neutropenia—Epirubicin—sarcoma	0.00152	0.00196	CcSEcCtD
Mitotane—Dizziness—Thiotepa—sarcoma	0.00152	0.00196	CcSEcCtD
Mitotane—Hypersensitivity—Vincristine—sarcoma	0.0015	0.00194	CcSEcCtD
Mitotane—Paraesthesia—Etoposide—sarcoma	0.00148	0.00191	CcSEcCtD
Mitotane—Somnolence—Etoposide—sarcoma	0.00147	0.00189	CcSEcCtD
Mitotane—Hypersensitivity—Mitoxantrone—sarcoma	0.00146	0.00189	CcSEcCtD
Mitotane—Asthenia—Vincristine—sarcoma	0.00146	0.00189	CcSEcCtD
Mitotane—Vomiting—Thiotepa—sarcoma	0.00146	0.00189	CcSEcCtD
Mitotane—Infestation NOS—Epirubicin—sarcoma	0.00145	0.00187	CcSEcCtD
Mitotane—Infestation—Epirubicin—sarcoma	0.00145	0.00187	CcSEcCtD
Mitotane—Drowsiness—Epirubicin—sarcoma	0.00145	0.00187	CcSEcCtD
Mitotane—Vomiting—Dactinomycin—sarcoma	0.00145	0.00187	CcSEcCtD
Mitotane—Rash—Thiotepa—sarcoma	0.00145	0.00187	CcSEcCtD
Mitotane—Dermatitis—Thiotepa—sarcoma	0.00145	0.00187	CcSEcCtD
Mitotane—Headache—Thiotepa—sarcoma	0.00144	0.00186	CcSEcCtD
Mitotane—Rash—Dactinomycin—sarcoma	0.00144	0.00186	CcSEcCtD
Mitotane—Decreased appetite—Etoposide—sarcoma	0.00143	0.00185	CcSEcCtD
Mitotane—Gastrointestinal disorder—Etoposide—sarcoma	0.00142	0.00184	CcSEcCtD
Mitotane—Asthenia—Mitoxantrone—sarcoma	0.00142	0.00184	CcSEcCtD
Mitotane—Pain—Etoposide—sarcoma	0.00141	0.00182	CcSEcCtD
Mitotane—Neutropenia—Doxorubicin—sarcoma	0.00141	0.00182	CcSEcCtD
Mitotane—Diarrhoea—Vincristine—sarcoma	0.00139	0.0018	CcSEcCtD
Mitotane—Haematuria—Epirubicin—sarcoma	0.00138	0.00179	CcSEcCtD
Mitotane—Hepatobiliary disease—Epirubicin—sarcoma	0.00137	0.00177	CcSEcCtD
Mitotane—Nausea—Thiotepa—sarcoma	0.00136	0.00176	CcSEcCtD
Mitotane—Feeling abnormal—Etoposide—sarcoma	0.00136	0.00176	CcSEcCtD
Mitotane—Diarrhoea—Mitoxantrone—sarcoma	0.00136	0.00175	CcSEcCtD
Mitotane—Nausea—Dactinomycin—sarcoma	0.00135	0.00175	CcSEcCtD
Mitotane—Dizziness—Vincristine—sarcoma	0.00135	0.00174	CcSEcCtD
Mitotane—Drowsiness—Doxorubicin—sarcoma	0.00134	0.00173	CcSEcCtD
Mitotane—Infestation—Doxorubicin—sarcoma	0.00134	0.00173	CcSEcCtD
Mitotane—Infestation NOS—Doxorubicin—sarcoma	0.00134	0.00173	CcSEcCtD
Mitotane—Body temperature increased—Etoposide—sarcoma	0.0013	0.00168	CcSEcCtD
Mitotane—Hepatitis—Epirubicin—sarcoma	0.0013	0.00168	CcSEcCtD
Mitotane—Vomiting—Vincristine—sarcoma	0.00129	0.00167	CcSEcCtD
Mitotane—Urinary tract disorder—Epirubicin—sarcoma	0.00128	0.00166	CcSEcCtD
Mitotane—Rash—Vincristine—sarcoma	0.00128	0.00166	CcSEcCtD
Mitotane—Dermatitis—Vincristine—sarcoma	0.00128	0.00166	CcSEcCtD
Mitotane—Haematuria—Doxorubicin—sarcoma	0.00128	0.00165	CcSEcCtD
Mitotane—Connective tissue disorder—Epirubicin—sarcoma	0.00128	0.00165	CcSEcCtD
Mitotane—Urethral disorder—Epirubicin—sarcoma	0.00128	0.00165	CcSEcCtD
Mitotane—Headache—Vincristine—sarcoma	0.00128	0.00165	CcSEcCtD
Mitotane—Hepatobiliary disease—Doxorubicin—sarcoma	0.00127	0.00164	CcSEcCtD
Mitotane—Vomiting—Mitoxantrone—sarcoma	0.00126	0.00163	CcSEcCtD
Mitotane—Visual impairment—Epirubicin—sarcoma	0.00125	0.00162	CcSEcCtD
Mitotane—Rash—Mitoxantrone—sarcoma	0.00125	0.00161	CcSEcCtD
Mitotane—Dermatitis—Mitoxantrone—sarcoma	0.00125	0.00161	CcSEcCtD
Mitotane—Headache—Mitoxantrone—sarcoma	0.00124	0.0016	CcSEcCtD
Mitotane—Eye disorder—Epirubicin—sarcoma	0.00122	0.00157	CcSEcCtD
Mitotane—Hypersensitivity—Etoposide—sarcoma	0.00121	0.00157	CcSEcCtD
Mitotane—Nausea—Vincristine—sarcoma	0.00121	0.00156	CcSEcCtD
Mitotane—Flushing—Epirubicin—sarcoma	0.00121	0.00156	CcSEcCtD
Mitotane—Hepatitis—Doxorubicin—sarcoma	0.0012	0.00156	CcSEcCtD
Mitotane—Urinary tract disorder—Doxorubicin—sarcoma	0.00119	0.00154	CcSEcCtD
Mitotane—Asthenia—Etoposide—sarcoma	0.00118	0.00153	CcSEcCtD
Mitotane—Connective tissue disorder—Doxorubicin—sarcoma	0.00118	0.00153	CcSEcCtD
Mitotane—Angiopathy—Epirubicin—sarcoma	0.00118	0.00153	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—sarcoma	0.00118	0.00152	CcSEcCtD
Mitotane—Nausea—Mitoxantrone—sarcoma	0.00118	0.00152	CcSEcCtD
Mitotane—Visual impairment—Doxorubicin—sarcoma	0.00116	0.0015	CcSEcCtD
Mitotane—Mental disorder—Epirubicin—sarcoma	0.00114	0.00147	CcSEcCtD
Mitotane—Malnutrition—Epirubicin—sarcoma	0.00113	0.00146	CcSEcCtD
Mitotane—Diarrhoea—Etoposide—sarcoma	0.00113	0.00146	CcSEcCtD
Mitotane—Eye disorder—Doxorubicin—sarcoma	0.00112	0.00145	CcSEcCtD
Mitotane—Flushing—Doxorubicin—sarcoma	0.00112	0.00144	CcSEcCtD
Mitotane—Dysgeusia—Epirubicin—sarcoma	0.00111	0.00143	CcSEcCtD
Mitotane—Angiopathy—Doxorubicin—sarcoma	0.00109	0.00141	CcSEcCtD
Mitotane—Dizziness—Etoposide—sarcoma	0.00109	0.00141	CcSEcCtD
Mitotane—Vision blurred—Epirubicin—sarcoma	0.00107	0.00138	CcSEcCtD
Mitotane—Mental disorder—Doxorubicin—sarcoma	0.00105	0.00136	CcSEcCtD
Mitotane—Vomiting—Etoposide—sarcoma	0.00105	0.00135	CcSEcCtD
Mitotane—Malnutrition—Doxorubicin—sarcoma	0.00105	0.00135	CcSEcCtD
Mitotane—Anaemia—Epirubicin—sarcoma	0.00105	0.00135	CcSEcCtD
Mitotane—Rash—Etoposide—sarcoma	0.00104	0.00134	CcSEcCtD
Mitotane—Dermatitis—Etoposide—sarcoma	0.00104	0.00134	CcSEcCtD
Mitotane—Headache—Etoposide—sarcoma	0.00103	0.00133	CcSEcCtD
Mitotane—Dysgeusia—Doxorubicin—sarcoma	0.00103	0.00133	CcSEcCtD
Mitotane—Vertigo—Epirubicin—sarcoma	0.00102	0.00131	CcSEcCtD
Mitotane—Vision blurred—Doxorubicin—sarcoma	0.000987	0.00128	CcSEcCtD
Mitotane—Nausea—Etoposide—sarcoma	0.000979	0.00127	CcSEcCtD
Mitotane—Hypertension—Epirubicin—sarcoma	0.000978	0.00126	CcSEcCtD
Mitotane—Anaemia—Doxorubicin—sarcoma	0.000968	0.00125	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000957	0.00124	CcSEcCtD
Mitotane—Vertigo—Doxorubicin—sarcoma	0.000941	0.00122	CcSEcCtD
Mitotane—Confusional state—Epirubicin—sarcoma	0.000932	0.0012	CcSEcCtD
Mitotane—Infection—Epirubicin—sarcoma	0.000918	0.00119	CcSEcCtD
Mitotane—Shock—Epirubicin—sarcoma	0.000909	0.00117	CcSEcCtD
Mitotane—Nervous system disorder—Epirubicin—sarcoma	0.000906	0.00117	CcSEcCtD
Mitotane—Thrombocytopenia—Epirubicin—sarcoma	0.000905	0.00117	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—sarcoma	0.000905	0.00117	CcSEcCtD
Mitotane—Skin disorder—Epirubicin—sarcoma	0.000898	0.00116	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000886	0.00114	CcSEcCtD
Mitotane—Anorexia—Epirubicin—sarcoma	0.000881	0.00114	CcSEcCtD
Mitotane—Hypotension—Epirubicin—sarcoma	0.000864	0.00112	CcSEcCtD
Mitotane—Confusional state—Doxorubicin—sarcoma	0.000862	0.00111	CcSEcCtD
Mitotane—Infection—Doxorubicin—sarcoma	0.00085	0.0011	CcSEcCtD
Mitotane—Shock—Doxorubicin—sarcoma	0.000841	0.00109	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—sarcoma	0.000839	0.00108	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—sarcoma	0.000837	0.00108	CcSEcCtD
Mitotane—Skin disorder—Doxorubicin—sarcoma	0.000831	0.00107	CcSEcCtD
Mitotane—Paraesthesia—Epirubicin—sarcoma	0.00083	0.00107	CcSEcCtD
Mitotane—Somnolence—Epirubicin—sarcoma	0.000822	0.00106	CcSEcCtD
Mitotane—Anorexia—Doxorubicin—sarcoma	0.000815	0.00105	CcSEcCtD
Mitotane—Dyspepsia—Epirubicin—sarcoma	0.000814	0.00105	CcSEcCtD
Mitotane—Decreased appetite—Epirubicin—sarcoma	0.000803	0.00104	CcSEcCtD
Mitotane—Hypotension—Doxorubicin—sarcoma	0.000799	0.00103	CcSEcCtD
Mitotane—Gastrointestinal disorder—Epirubicin—sarcoma	0.000798	0.00103	CcSEcCtD
Mitotane—Pain—Epirubicin—sarcoma	0.00079	0.00102	CcSEcCtD
Mitotane—Paraesthesia—Doxorubicin—sarcoma	0.000768	0.000992	CcSEcCtD
Mitotane—Feeling abnormal—Epirubicin—sarcoma	0.000762	0.000984	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—sarcoma	0.00076	0.000982	CcSEcCtD
Mitotane—Dyspepsia—Doxorubicin—sarcoma	0.000753	0.000973	CcSEcCtD
Mitotane—Decreased appetite—Doxorubicin—sarcoma	0.000743	0.000961	CcSEcCtD
Mitotane—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000738	0.000954	CcSEcCtD
Mitotane—Pain—Doxorubicin—sarcoma	0.000731	0.000945	CcSEcCtD
Mitotane—Body temperature increased—Epirubicin—sarcoma	0.000731	0.000944	CcSEcCtD
Mitotane—Feeling abnormal—Doxorubicin—sarcoma	0.000705	0.000911	CcSEcCtD
Mitotane—Hypersensitivity—Epirubicin—sarcoma	0.000681	0.00088	CcSEcCtD
Mitotane—Body temperature increased—Doxorubicin—sarcoma	0.000676	0.000874	CcSEcCtD
Mitotane—Asthenia—Epirubicin—sarcoma	0.000663	0.000857	CcSEcCtD
Mitotane—Diarrhoea—Epirubicin—sarcoma	0.000632	0.000817	CcSEcCtD
Mitotane—Hypersensitivity—Doxorubicin—sarcoma	0.00063	0.000814	CcSEcCtD
Mitotane—Asthenia—Doxorubicin—sarcoma	0.000614	0.000793	CcSEcCtD
Mitotane—Dizziness—Epirubicin—sarcoma	0.000611	0.00079	CcSEcCtD
Mitotane—Vomiting—Epirubicin—sarcoma	0.000588	0.000759	CcSEcCtD
Mitotane—Diarrhoea—Doxorubicin—sarcoma	0.000585	0.000756	CcSEcCtD
Mitotane—Rash—Epirubicin—sarcoma	0.000583	0.000753	CcSEcCtD
Mitotane—Dermatitis—Epirubicin—sarcoma	0.000582	0.000752	CcSEcCtD
Mitotane—Headache—Epirubicin—sarcoma	0.000579	0.000748	CcSEcCtD
Mitotane—Dizziness—Doxorubicin—sarcoma	0.000565	0.000731	CcSEcCtD
Mitotane—Nausea—Epirubicin—sarcoma	0.000549	0.000709	CcSEcCtD
Mitotane—Vomiting—Doxorubicin—sarcoma	0.000544	0.000703	CcSEcCtD
Mitotane—Rash—Doxorubicin—sarcoma	0.000539	0.000697	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—sarcoma	0.000539	0.000696	CcSEcCtD
Mitotane—Headache—Doxorubicin—sarcoma	0.000536	0.000692	CcSEcCtD
Mitotane—Nausea—Doxorubicin—sarcoma	0.000508	0.000656	CcSEcCtD
